论文部分内容阅读
应用免疫抑制剂治疗成年人慢性肾小球肾炎(简称慢性肾炎)尚有争议,目前认为免疫抑制剂仅仅对微小病变型的肾小球肾炎和狼疮性肾炎有效。作者对70例慢性肾炎应用泼尼松龙治疗进行了观察。70例慢性肾炎中不包括微小病变型,其中灶性增殖性慢性肾炎8例,膜性增殖性肾炎8例,膜性肾炎22例,肾炎合并肾盂肾炎17例,毛细血管外增殖性8例,毛细血管内增殖性7例,泼尼松龙开始用量绝大多数为100mg/日,维持剂量为10～20mg/日,甲均治疗时间分别为14.9月、15月、14.9月、10.1月,17.3月、17月。
The use of immunosuppressive therapy for chronic glomerulonephritis in adults (referred to as chronic glomerulonephritis) is still controversial, immunosuppressants are currently considered only for minimally pathological glomerulonephritis and lupus nephritis effective. The author of 70 cases of chronic nephritis treated with prednisolone were observed. 70 cases of chronic nephritis does not include minor lesions, including focal proliferative chronic nephritis in 8 cases, membranous proliferative glomerulonephritis in 8 cases, membranous nephritis in 22 cases, nephritis with pyelonephritis in 17 cases, extracapillary proliferative in 8 cases, Capillaries proliferative in 7 cases, prednisolone the vast majority of the initial dose of 100mg / day, the maintenance dose of 10 ~ 20mg / day, a treatment time was 14.9 months, 15 months, 14.9 months, 10.1 months, 17.3 Month, 17 months.